Szela Mary T
CIK 0001410289
CEO and PresidentDirector
Filings
22
Latest May 18, 2026
Issuers covered
5
Showing
22 of 22
Page 1
Track record
11 of 12 open-market trades scored (92% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 36% | -2.2% | -4.0% | +17.8% | -19.6% |
| 90 days | 9 | 44% | -6.8% | -12.2% | +17.0% | -35.5% |
| 180 days | 8 | 25% | -2.2% | -6.8% | +17.3% | -15.1% |
| 365 days | 8 | 38% | -2.3% | -1.0% | +2.0% | -13.8% |
Issuers
Companies where Szela Mary T has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TLSI | Trisalus Life Sciences, Inc. | 11 | May 18, 2026 |
| KURA | Kura Oncology, Inc. | 4 | Jun 6, 2025 |
| OMGA | Omega Therapeutics, Inc. | 3 | Jun 21, 2024 |
| RXDX | Prometheus Biosciences, Inc. | 3 | Jun 16, 2023 |
| ABSI | Absci Corp | 1 | Jul 9, 2025 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|